Michael Devoy
Job title
EVP, Chief Medical Officer
Company
Bayer
2025 Ophthalmology Futures Forums participation
Retina Forum, Paris 2025
11:20 - 11:50
Panel 3: Neovascular AMD: Are the Novel Extended Interval Therapies Truly Making a Difference?
EVP, Chief Medical Officer
Bayer
Retina Forum, Paris 2025
11:20 - 11:50
Panel 3: Neovascular AMD: Are the Novel Extended Interval Therapies Truly Making a Difference?